CCP
KRTX

Clough Capital Partners’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Clough Capital Partners’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,040
Closed -$646K – 203
2023
Q4 		$646K Sell
2,040
-29,890
-94% -$5.81M 0.07% 127
2023
Q3 		$5.4M Buy
+31,930
New +$6M 0.58% 55

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Clough Capital Partners's KRTX Position: Q1 2024 in Review

Clough Capital Partners sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,040 shares — an estimated $646K sold.

Clough Capital Partners first reported a position in KRTX in Q3 2023 and held it in 2 quarters. The position peaked at $5.4M in Q3 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Clough Capital Partners reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Clough Capital Partners sold 2,040 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $646K.
  • Clough Capital Partners first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Clough Capital Partners's Karuna Therapeutics, Inc. Common Stock position peaked at $5.4M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Clough Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.